These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8322487)

  • 21. Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein.
    Bauer MJ; Georgousakis MM; Vu T; Henningham A; Hofmann A; Rettel M; Hafner LM; Sriprakash KS; McMillan DJ
    Vaccine; 2012 Mar; 30(12):2197-205. PubMed ID: 22265945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
    Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
    J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.
    Bessen D; Fischetti VA
    Infect Immun; 1988 Oct; 56(10):2666-72. PubMed ID: 2458320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination of pony foals with M-like protein of Streptococcus equi.
    Srivastava SK; Barnum DA
    Am J Vet Res; 1983 Jan; 44(1):41-5. PubMed ID: 6824223
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein.
    Lin HX; Huang DY; Wang Y; Lu CP; Fan HJ
    Vaccine; 2011 Sep; 29(40):7027-34. PubMed ID: 21807055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.
    Beachey EH; Stollerman GH; Johnson RH; Ofek I; Bisno AL
    J Exp Med; 1979 Oct; 150(4):862-77. PubMed ID: 390084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.
    Chuan YP; Wibowo N; Connors NK; Wu Y; Hughes FK; Batzloff MR; Lua LH; Middelberg AP
    Biotechnol Bioeng; 2014 Jun; 111(6):1062-70. PubMed ID: 24338691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium.
    Baird RW; Bronze MS; Kraus W; Hill HR; Veasey LG; Dale JB
    J Immunol; 1991 May; 146(9):3132-7. PubMed ID: 2016540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against streptococcal pharyngeal colonization with a vaccinia: M protein recombinant.
    Fischetti VA; Hodges WM; Hruby DE
    Science; 1989 Jun; 244(4911):1487-90. PubMed ID: 2660266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The conserved surface M-protein SiMA of Streptococcus iniae is not effective as a cross-protective vaccine against differing capsular serotypes in farmed fish.
    Aviles F; Zhang MM; Chan J; Delamare-Deboutteville J; Green TJ; Dang C; Barnes AC
    Vet Microbiol; 2013 Feb; 162(1):151-9. PubMed ID: 22989514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.
    Olive C; Clair T; Yarwood P; Good MF
    Vaccine; 2002 Jun; 20(21-22):2816-25. PubMed ID: 12034109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS.
    Smeesters PR; Dramaix M; Van Melderen L
    Vaccine; 2010 Jan; 28(4):883-5. PubMed ID: 19963033
    [No Abstract]   [Full Text] [Related]  

  • 33. Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
    Dale JB; Smeesters PR; Courtney HS; Penfound TA; Hohn CM; Smith JC; Baudry JY
    Vaccine; 2017 Jan; 35(1):19-26. PubMed ID: 27890396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
    J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate.
    Batzloff MR; Fane A; Gorton D; Pandey M; Rivera-Hernandez T; Calcutt A; Yeung G; Hartas J; Johnson L; Rush CM; McCarthy J; Ketheesan N; Good MF
    Hum Vaccin Immunother; 2016 Dec; 12(12):3089-3096. PubMed ID: 27541593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.
    McNeil SA; Halperin SA; Langley JM; Smith B; Warren A; Sharratt GP; Baxendale DM; Reddish MA; Hu MC; Stroop SD; Linden J; Fries LF; Vink PE; Dale JB
    Clin Infect Dis; 2005 Oct; 41(8):1114-22. PubMed ID: 16163629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
    Bronze MS; Courtney HS; Dale JB
    J Immunol; 1992 Feb; 148(3):888-93. PubMed ID: 1370521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Streptococcal M protein.
    Fischetti VA
    Sci Am; 1991 Jun; 264(6):58-65. PubMed ID: 1857955
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.
    Pastural É; McNeil SA; MacKinnon-Cameron D; Ye L; Langley JM; Stewart R; Martin LH; Hurley GJ; Salehi S; Penfound TA; Halperin S; Dale JB
    Vaccine; 2020 Feb; 38(6):1384-1392. PubMed ID: 31843270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity evoked by locally administered group A streptococcal vaccines in mice.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    J Immunol; 1988 Oct; 141(8):2767-70. PubMed ID: 3049817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.